Literature DB >> 26077609

Systematic Review of Measles and Rubella Serology Studies.

Kimberly M Thompson1,2, Cassie L Odahowski1.   

Abstract

Serological tests provide information about individual immunity from historical infection or immunization. Cross-sectional serological studies provide data about the age- and sex-specific immunity levels for individuals in the studied population, and these data can provide a point of comparison for the results of transmission models. In the context of developing an integrated model for measles and rubella transmission, we reviewed the existing measles and rubella literature to identify the results of national serological studies that provided cross-sectional estimates of population immunity at the time of data collection. We systematically searched PubMed, the Science Citation Index, and references we identified from relevant articles published in English. We extracted serological data for comparison to transmission model outputs. For rubella, serological studies of women of child-bearing age provide information about the potential risks of infants born with congenital rubella syndrome. Serological studies also document the loss of maternal antibodies, which occurs at different rates for the different viruses and according to the nature of the induced immunity (i.e., infection or vaccine). The serological evidence remains limited for some areas, with studies from developed countries representing a disproportionate part of the evidence. The collection and review of serological evidence can help program managers identify immunity gaps in the population, which may help them better understand the characteristics of individuals within their populations who may participate in transmission and manage risks.
© 2015 Society for Risk Analysis.

Entities:  

Keywords:  Immunization; measles; rubella; serology

Mesh:

Substances:

Year:  2015        PMID: 26077609     DOI: 10.1111/risa.12430

Source DB:  PubMed          Journal:  Risk Anal        ISSN: 0272-4332            Impact factor:   4.000


  8 in total

Review 1.  Current perspectives in assessing humoral immunity after measles vaccination.

Authors:  Iana H Haralambieva; Richard B Kennedy; Inna G Ovsyannikova; Daniel J Schaid; Gregory A Poland
Journal:  Expert Rev Vaccines       Date:  2018-12-26       Impact factor: 5.683

2.  Risk analysis for the reintroduction and transmission of measles in the post-elimination period in the Americas.

Authors:  Daniele Rocha Queiroz Lemos; Aidee Ramirez Franco; Marcio Henrique de Oliveira Garcia; Desiree Pastor; Pamela Bravo-Alcantara; Jose Cassio de Moraes; Carla Domingues; Luciano Pamplona de Goes Cavalcanti
Journal:  Rev Panam Salud Publica       Date:  2017-12-20

Review 3.  Mumps Outbreaks in Vaccinated Populations-Is It Time to Re-assess the Clinical Efficacy of Vaccines?

Authors:  Anna R Connell; Jeff Connell; T Ronan Leahy; Jaythoon Hassan
Journal:  Front Immunol       Date:  2020-09-18       Impact factor: 7.561

Review 4.  Seroprevalence of ToRCH Pathogens in Southeast Asia.

Authors:  Franziska E Fuchs; Maude Pauly; Antony P Black; Judith M Hübschen
Journal:  Microorganisms       Date:  2021-03-11

5.  Prevalence and management of rubella susceptibility in healthcare workers in Italy: A systematic review and meta-analysis.

Authors:  Francesco Paolo Bianchi; Pasquale Stefanizzi; Giusy Diella; Andrea Martinelli; Antonio Di Lorenzo; Maria Serena Gallone; Silvio Tafuri
Journal:  Vaccine X       Date:  2022-08-07

6.  Evaluation of vaccination status of health care workers for recommended vaccines and their acceptance of SARS-CoV-2 vaccines.

Authors:  Pembe Derin Oygar; Ayşe Büyükçam; Zumrut Sahbudak Bal; Nazan Dalgıç; Şefika Elmas Bozdemir; Adem Karbuz; Benhur Şirvan Çetin; Yalçın Kara; Ceren Çetin; Nevin Hatipoğlu; Hatice Uygun; Fatma Deniz Aygün; Selda Hançerli Törün; Dicle Şener Okur; Dilek Yılmaz Çiftdoğan; Tuğçe Tural Kara; Aysun Yahşi; Arife Özer; Sevliya Öcal Demir; Gülşen Akkoç; Cansu Turan; Enes Salı; Semra Şen; Emine Hafize Erdeniz; Soner Sertan Kara; Melike Emiroğlu; Tuğba Erat; Hacer Aktürk; Sibel Laçinel Gürlevik; Murat Sütçü; Zeynep Gökçe Gayretli Aydın; Başak Yıldız Atikan; Edanur Yeşil; Gizem Güner Özenen; Emel Çelebi; Kadir Efe; Didem Kizmaz Isancli; Habibe Selver Durmuş; Seher Tekeli; Ayşe Karaaslan; Lida Bülbül; Habip Almış; Özge Kaba; Yıldız Ekemen Keleş; Bahadır Yazıcıoğlu; Serife Bahtiyar Oğuz; Hüsnü Fahri Ovalı; Hazal Helin Doğan; Solmaz Çelebi; Deniz Çakir; Burcugül Karasulu; Gülsüm Alkan; İrem Yenidoğan; Doruk Gül; Burcu Parıltan Kücükalioğlu; Gülhadiye Avcu; Musa Gürel Kukul; Melis Bilen; Belma Yaşar; Tuğba Üstün; Ömer Kılıç; Yasemin Akın; Sinem Oral Cebeci; İbrahim Hakan Bucak; Mehpare Sarı Yanartaş; Aslıhan Şahin; Sertaç Arslanoglu; Murat Elevli; Rabia Çoban; Sadiye Kübra Tuter Öz; Halil Hatipoğlu; İlyas Tolga Erkum; Mehmet Turgut; Asuman Demirbuğa; Taha Özçelik; Diclehan Çiftçi; Emine Ergül Sarı; Gökhan Akkuş; Sadık Sami Hatipoğlu; Ener Cağrı Dinleyici; Mustafa Hacimustafaoğlu; Ferda Özkınay; Zafer Kurugöl; Ali Bulent Cengiz; Ayper Somer; Hasan Tezer; Ateş Kara
Journal:  Hum Vaccin Immunother       Date:  2022-06-17       Impact factor: 4.526

7.  A Survey of Vaccine-Induced Measles IgG Antibody Titer to Verify Temporal Changes in Response to Measles Vaccination in Young Adults.

Authors:  Hiraku Sasaki; Tomoko Fukunaga; Ai Asano; Yoshio Suzuki; Yuko Nakanishi; Junzi Kondo; Hiroki Ishikawa; Nobuto Shibata
Journal:  Vaccines (Basel)       Date:  2019-09-19

8.  How much does it cost to measure immunity? A costing analysis of a measles and rubella serosurvey in southern Zambia.

Authors:  Andrea C Carcelen; Kyla Hayford; William J Moss; Christopher Book; Philip E Thuma; Francis D Mwansa; Bryan Patenaude
Journal:  PLoS One       Date:  2020-10-15       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.